Health Care • Biotechnology: Pharmaceutical Preparations
$11.31 ▲ +0.38
(+3.43%)
MKT CAP: $277.0M • VOL: 149.2K
52W L $7 52W H $45
ROARABLE / RQD
D- • 38/100
PIOTROSKI
3 / 9
LYEL CHAT <GO> // SEC 10-K & XBRL FORENSIC RAGLyell Immunopharma Inc. • CIK 0001806952
EDGAR XBRL + ITEM 1A/7FREE QUERIES: 2/2
INSTITUTIONAL AUDIT PROMPTS [CLICK TO EXECUTE]STRUCTURED CITATION ENGINE
[READY // SEC EDGAR & XBRL VECTOR WORKSTATION]
Select an audit prompt above or enter any fundamental, 10-K Risk Factor (Item 1A), MD&A (Item 7), free cash flow conversion, or FRED macro-correlation query on LYEL. Every response cites verified XBRL line items and SEC filing sections.